Vega, Lorena R.
HRN: 17-79-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2026
AMPICILLIN 1GM (VIAL)
07/21/2026
07/22/2026
IVTT
2g
Q6h
Thickly MSAF
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: